Myth or coverage: experience and expectation of policyholders from health insurance during COVID-19 in the NCR region of India

Author:

Singhal Nikita,Sultana Almas,Goyal Shikha

Abstract

AbstractThis study intends to determine whether and to what extent policyholders admitted to the hospital for COVID-19 treatment receive financial support from their health insurance. The researcher interviewed 67 health insurance claimants in the NCR region's several cities—some in Uttar Pradesh, Delhi, Haryana, and Rajasthan. They also interviewed various insurance system participants, including branch managers, agents, and hospital staff, to obtain an overview of policyholder experiences and insurer challenges. For analysis, qualitative research techniques have been used. This research is helpful in various situations when people are hospitalised for planned and unanticipated reasons by recommending what insurance companies should do to protect the interests of their customers. For the Indian insurance industry and regulator/supervisory authorities, the COVID-19 pandemic incidents can be a lesson about their strengths and weaknesses. According to this research, service-level agreement violations, procedural bottlenecks, and lack of clarity and awareness are the problems policyholders face when pursuing claims. The challenges insurers confront in serving their client's needs are maintaining operations in the face of financial stress and changing regulatory compliances, on the one hand, and helping policyholders by resolving their claims and raising awareness, on the other.

Funder

ICSSR

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Reference19 articles.

1. Saraswathy M, Pilla V (2020) Insurers, hospitals continue to slog it out over treatment costs while patients suffer. https://www.moneycontrol.com/news/business/economy/insurers-hospitals-continue-to-slog-it-out-over-treatment-costs-while-patients-suffer-5758201.html Accessed 23 Mar 2023

2. IRDAI (2021) Communication on settlement of health insurance claims against general insurance council's instructions dated June 20 2020, on "reference rates for COVID-19". https://www.irdai.gov.in/ADMINCMS/cms/whatsNew_Layout.aspx?page=PageNo4338&flag=1. Accessed 04 Jan 2023

3. IRDAI (2021) Communication on health insurance claims. https://www.irdai.gov.in/ADMINCMS/cms/frmGeneral_Layout.aspx?page=PageNo4458&flag=1. Accessed 12 Jan 2023

4. IRDAI (2021) Norms on settlement of COVID-19 health insurance claims. https://www.irdai.gov.in/ADMINCMS/cms/Circulars_Layout.aspx?page=PageNo4465&flag=1. Accessed 27 Dec 2022

5. IRDAI (2020) Guidelines on settlement of claims on treatment at 'make-shift or temporary hospitals' as permitted by government. https://www.irdai.gov.in/ADMINCMS/cms/Circulars_Layout.aspx?page=PageNo4189&flag=1. Accessed 27 Dec 2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3